2025 Global Market Share: The Dominance of GSK and Cipla
By late 2025, the global nasal spray market has consolidated significantly, with the top two manufacturers alone controlling approximately 27% of the total market share. GlaxoSmithKline (GSK) remains the global leader with a 15% share, driven by its robust portfolio of 12 branded products, including Avamys and Veramyst. GSK's focus in 2025 has shifted toward "circular economy" initiatives,...
0 Комментарии 0 Поделились 93 Просмотры 0 предпросмотр
SMG https://sharemeglobal.com